“…Regarding ascitic fluid PGE2, there is a substantial difference between the two cohorts, indicating that the greater the hospital mortality rate for diseased individuals with hepatic cirrhosis, the lower the ascitic fluid PGE2. In agreement with our findings, Aboghiaty et al (10) found no association between case cohort mortality, ascitic fluid, and serum PGDE2 before and after treatment. Additionally, MELD score and advanced age were independent predictors of death in multivariate analysis (34).…”